{"url_path":"/sec/mdwk/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1295514/0001493152-26-023433-index.html","accession_number":"0001493152-26-023433","cik":"0001295514","ticker":"MDWK","issuer_name":"MDWerks, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1295514/0001493152-26-023433-index.html","primary_entity_key":"0001295514","primary_entity_name":"MDWerks, Inc."},"word_count":92,"has_tables":true,"body_markdown":"**Item\n5. Other Information.**\n\n** **\n\n(a)\nNone.\n\n \n\n(b)\nThere have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors since\nwe last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.\n\n \n\n(c)\nDuring the quarter ended March 31, 2026, no director or officer adopted or terminated a contract, instruction or written plan for the\npurchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or a non-Rule\n10b5-1 trading arrangement.\n\n \n\n9"}